GlassScriptPhysician profile
Sundeep Das
NPI 1548274749
$30,608.37
in general payments reported to CMS, 2019-2025
62 companies · $1,175 in 2025
The $1,175 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,354 · 2020: $8,509 · 2021: $12K · 2022: $2,381 · 2023: $2,229 · 2024: $1,603 · 2025: $1,175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,712 · Consulting Fee: $219 · Education: $75.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,712.25 |
| Consulting Fee | $219.49 |
| Education | $75.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $18,064.50 | 2019-2025 | Auryon Laser System 100-120 Vac, Alphavac |
| Novartis Pharmaceuticals Corporation | $1,730.33 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $757.45 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $554.61 | 2019-2025 | Brilinta, Farxiga, Wainua |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $539.36 | 2019-2022 | |
| Amgen INC. | $514.70 | 2019-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $507.21 | 2019-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $485.56 | 2021-2025 | Verquvo, Winrevair |
| Boehringer Ingelheim Pharmaceuticals, INC. | $474.87 | 2019-2025 | Jardiance |
| Pfizer INC. | $410.78 | 2019-2025 | |
| Abbott Laboratories | $398.56 | 2020-2025 | Diamondback Coronary, Jot Dx, Diamondback Peripheral |
| Corcept Therapeutics | $388.69 | 2022-2024 | Korlym |
| Cardiovascular Systems INC. | $333.56 | 2020-2021 | |
| Actelion Pharmaceuticals US, INC. | $326.94 | 2019-2023 | Opsumit |
| Boston Scientific Corporation | $326.03 | 2019-2022 |
Show all 62 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $325.87 | 2019-2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Impulse Dynamics (USA) INC. | $279.51 | 2021-2023 | Optimizer |
| Bayer Healthcare Pharmaceuticals INC. | $279.38 | 2019-2025 | |
| Gilead Sciences, INC. | $256.04 | 2019 | |
| Alnylam Pharmaceuticals INC. | $251.23 | 2019-2025 | Onpattro |
| Sanofi-Aventis U.S. LLC | $248.51 | 2019-2024 | |
| Vifor Pharma, INC. | $244.17 | 2019-2021 | |
| Jenavalve Technology, INC. | $219.49 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $172.72 | 2024 | Arcalyst |
| Esperion Therapeutics, INC. | $154.67 | 2020-2025 | Nexletol |
| Daiichi Sankyo INC. | $153.29 | 2020-2023 | Injectafer |
| Novo Nordisk INC | $151.85 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Regeneron Healthcare Solutions, INC. | $144.03 | 2019-2023 | Praluent, Evkeeza |
| Biotronik INC. | $141.51 | 2022-2023 | Orsiro Mission |
| Cvrx, INC. | $134.94 | 2019-2021 | |
| Lexicon Pharmaceuticals, INC. | $130.04 | 2023-2024 | Inpefa |
| Astellas Pharma US INC | $123.84 | 2019 | |
| Biosense Webster, INC. | $122.32 | 2024 | Carto 3 |
| Philips North America LLC | $118.57 | 2019-2024 | (Az7) Lasers, (Bs1) Peripheral Vascular Undivided |
| Kiniksa Pharmaceuticals, LTD. | $114.65 | 2023 | Arcalyst |
| Genzyme Corporation | $83.63 | 2023 | |
| United Therapeutics Corporation | $78.39 | 2019-2023 | Tyvaso |
| Lilly USA, LLC | $77.05 | 2019-2021 | |
| Lundbeck LLC | $75.18 | 2019-2020 | |
| Kestra Medical Technology Services, INC. | $71.32 | 2022-2025 | Assure Wcd |
| Cleerly, INC. | $70.30 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Scpharmaceuticals INC. | $55.77 | 2023-2025 | |
| Reflow Medical INC | $53.26 | 2024 | |
| Amarin Pharma, INC. | $50.06 | 2020-2021 | |
| Medtronic, INC. | $43.83 | 2021-2022 | |
| Livanova USA, INC. | $34.70 | 2022 | |
| Resmed Corp | $34.40 | 2025 | |
| Itamar Medical INC | $28.86 | 2024 | Watchpatone |
| Abiomed | $28.47 | 2024 | Impella |
| Arbor Pharmaceuticals, INC. | $26.59 | 2019-2020 | |
| Medtronic Vascular, INC. | $23.14 | 2019 | |
| Chiesi USA, INC. | $20.25 | 2024 | Juxtapid |
| Inari Medical, INC. | $20.09 | 2021 | |
| Pharmacosmos Therapeutics INC. | $19.74 | 2020 | |
| Stryker Corporation | $19.67 | 2025 | Flowtriever |
| Cook Medical LLC | $18.76 | 2022 | |
| Bard Peripheral Vascular, INC. | $18.09 | 2020 | |
| Tactile Systems Technology INC | $17.13 | 2025 | Nimbl, Flexitouch Plus |
| Inspire Medical Systems, INC. | $16.27 | 2023 | Inspire |
| Otsuka America Pharmaceutical, INC. | $15.98 | 2019 | |
| Irhythm Technologies, INC. | $14.47 | 2024 | Zio Monitor, Zio Xt Patch |
| Amryt Pharma Holdings LTD | $13.19 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sundeep Das listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.